188
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Transcription Factor STAT1 Promotes the Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells by Upregulating LINC01160

, , , , , , & ORCID Icon show all
Pages 57-69 | Received 15 Jun 2020, Accepted 01 Oct 2020, Published online: 02 Dec 2020

References

  • Lee AW , NgWT, ChanYH, SzeH, ChanC, LamTH. The battle against nasopharyngeal cancer. Radiother. Oncol.104(3), 272–278 (2012).
  • Lo KW , ChungGT, ToKF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin. Cancer Biol.22(2), 79–86 (2012).
  • Kim YS , KimBS, JungSLet al. Radiation therapy combined with (or without) cisplatin-based chemotherapy for patients with nasopharyngeal cancer: 15-years experience of a single institution in Korea. Cancer Res. Treat.40(4), 155–163 (2008).
  • Lin C , YangL. Long noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol.28(4), 287–301 (2018).
  • Butler AA , WebbWM, LubinFD. Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction. Epigenomics8(1), 135–151 (2016).
  • Kanduri C . Long noncoding RNAs: lessons from genomic imprinting. Biochim. Biophys. Acta1859(1), 102–111 (2016).
  • Yue M , CharlesRichard JL, OgawaY. Dynamic interplay and function of multiple noncoding genes governing X chromosome inactivation. Biochim. Biophys. Acta1859(1), 112–120 (2016).
  • Serviss JT , JohnssonP, GranderD. An emerging role for long non-coding RNAs in cancer metastasis. Front. Genet.5, 234 (2014).
  • Schmitt AM , ChangHY. Long noncoding RNAs in cancer pathways. Cancer Cell29(4), 452–463 (2016).
  • Stark GR , DarnellJEJr. The JAK–STAT pathway at twenty. Immunity36(4), 503–514 (2012).
  • Yu N , XueM, WangWet al. RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1. J. Cell. Mol. Med.23(2), 1553–1561(2018).
  • Hou Y , LiX, LiQet al. STAT1 facilitates oestrogen receptor alpha transcription and stimulates breast cancer cell proliferation. J. Cell. Mol. Med.22(12), 6077–6086 (2018).
  • Huang J , ZhengC, ShaoJ, ChenL, LiuX, ShaoJ. Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway. Biochem. Biophys. Res. Commun.494(3-4), 542–549 (2017).
  • Qu S , GuoY, HuangST, ZhuXD. Inhibition of STAT1 sensitizes radioresistant nasopharyngeal carcinoma cell line CNE-2R to radiotherapy. Oncotarget9(9), 8303–8310 (2018).
  • Zeng PY , VakocCR, ChenZC, BlobelGA, BergerSL. In vivo dual cross-linking for identification of indirect DNA-associated proteins by chromatin immunoprecipitation. Biotechniques41(6), 694, 696, 698 (2006).
  • Hao J , ZhangYJ, LvXet al. IFN-γ induces lipogenesis in mouse mesangial cells via the JAK2/STAT1 pathway. Am. J. Physiol. Cell Physiol.304(8), C760–767 (2013).
  • Yang SH , LiL, XieYQet al. IFN-γ–STAT1–iNOS induces myeloid progenitors to acquire immunosuppressive activity. Front. Immunol.8, 1192 (2017).
  • Xu M , YaoY, ChenHet al. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. Nat. Genet.51(7), 1131–1136 (2019).
  • Ooft ML , van IpenburgJA, BrauniusWW, ZuurCI, KoljenovićS, WillemsSM. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma. Oral Oncol.71, 16–25 (2017).
  • Barros MH , SeggesP, Vera-LozadaG, HassanR, NiedobitekG. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.PLoS ONE10(5), e0124531 (2015).
  • Kong XF , WorleyL, RinchaiDet al. Three copies of four interferon receptor genes underlie a mild Type I interferonopathy in Down syndrome. J. Clin. Immunol.40(6), 807–819 (2020).
  • O’shea JJ , HollandSM, StaudtLM. JAKs and STATs in immunity, immunodeficiency, and cancer. N. Engl. J. Med.368(2), 161–170 (2013).
  • Adamkova L , SouckovaK, KovarikJ. Transcription protein STAT1: biology and relation to cancer. Folia Biol. (Praha)53(1), 1–6 (2007).
  • Chen J , ZhaoJ, ChenLet al. STAT1 modification improves therapeutic effects of interferons on lung cancer cells. J. Transl. Med.13, 293 (2015).
  • Dorritie KA , MccubreyJA, JohnsonDE. STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia28(2), 248–257 (2014).
  • Zhang X , LiX, TanF, YuN, PeiH. STAT1 inhibits MiR-181a expression to suppress colorectal cancer cell proliferation through PTEN/Akt. J. Cell. Biochem.118(10), 3435–3443 (2017).
  • Buettner R , MoraLB, JoveR. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res.8(4), 945–954 (2002).
  • Arzt L , KothmaierH, HalbwedlI, QuehenbergerF, PopperHH. Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma. Virchows Arch.465(1), 79–88 (2014).
  • Greenwood C , MetodievaG, Al-JanabiKet al. Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer. J. Proteomics75(10), 3031–3040 (2012).
  • Khodarev NN , BeckettM, LabayE, DargaT, RoizmanB, WeichselbaumRR. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc. Natl Acad. Sci. USA101(6), 1714–1719 (2004).
  • Ma H , YangW, ZhangLet al. Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma. Br. J. Cancer120(3), 317–330(2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.